Geron | GERN - Debt

Stock Price
1.77
Daily Change
0.02 1.14%
Monthly
9.26%
Yearly
38.28%
Q2 Forecast
1.61

Geron reported $121.92M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Amgen USD 54.59B 1.62B Sep/2025
Bio Techne USD 260M 40M Dec/2025
Cassava Sciences USD 0 0 Dec/2024
Cytokinetics USD 1.2B 338.79M Sep/2025
Esperion Therapeutics USD 262.92M 1.76M Sep/2024
Exelixis USD 176.46M 3.38M Sep/2025
Genmab DKK 148M 5M Jun/2025
Geron USD 121.92M 73K Sep/2025
Gilead Sciences USD 24.94B 5M Sep/2025
Incyte USD 40.41M 855K Dec/2025
MacroGenics USD 37.01M 238K Sep/2025
Novartis USD 32.64B 1.37B Jun/2025
Novavax USD 233.31M 4.23M Sep/2024